Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute. Learn more about Cancer Currents.
-
Approach May Allow for Stem Cell Transplant without Radiation, Chemotherapy
In a recent study, researchers showed that a new approach may provide a safer way to perform stem cell transplants for treating cancer and other diseases.
-
Engineered Stem Cells Help Identify Potential New Treatment for Medulloblastoma
Stem cells engineered to mimic medulloblastoma development may help researchers identify potential new treatments, according to a new study.
-
Tumor DNA in Blood May Signal Response to T-Cell Transfer Immunotherapy
A study suggests that doctors could use circulating tumor DNA to quickly identify patients who are responding to T-cell transfer immunotherapy.
-
New on NCI’s Websites for August 2016
An NCI Cancer Currents blog post that provides updates on new NCI websites and other online content of interest to the cancer community.
-
FDA Approves Pembrolizumab for Head and Neck Cancer
FDA granted pembrolizumab an accelerated approval for patients with recurrent or metastatic head and neck cancer that has continued to progress despite standard treatment with chemotherapy.
-
Nanoparticle that Mimics Salmonella Counteracts Chemotherapy Resistance
A nanoparticle that mimics Salmonella may help to counteract chemotherapy resistance, according to a new study.
-
CA-125 Testing, CT Scans Still Used for Ovarian Cancer Surveillance Despite Lack of Proven Benefit
A new study shows clinicians continue to use CA-125 testing and CT scans to monitor for recurrences although the benefit of these tests has not been proven.
-
Adolescents Who Wouldn’t Have Smoked May Be Drawn to E-Cigarettes
The findings from a recent study suggest that adolescents are not just using e-cigarettes as a substitute for conventional cigarettes but that e-cigarettes are attracting new users to tobacco products.
-
Mutations Linked to Immunotherapy Resistance
Researchers identified mutations in relapsed melanoma tumors that block the anticancer effects of the checkpoint inhibitor pembrolizumab.
-
Nanoparticle Delivers Cancer Drugs to Tumor Blood Vessels
In cancer mouse models, nanoparticles that bind to a protein called P-selectin on tumor blood vessels shrank tumors and extended survival.
-
Partner-Aided Skin Exams Increase Early Detection of New Melanomas
People previously treated for melanoma can team up with a spouse, family member, or a friend and be trained to find new melanomas, a new study shows.
-
Inherited Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
Researchers estimate that nearly 12% of men with advanced prostate cancer have inherited mutations in genes that play a role in repairing damaged DNA.
-
Olanzapine Helps Prevent Nausea and Vomiting Caused by Chemotherapy
A drug currently used to treat several psychiatric conditions can help prevent nausea and vomiting in patients receiving chemotherapy, a large clinical trial showed.
-
Anthrax Toxin-Based Cancer Therapy Targets Tumor Blood Vessels
A therapy that uses the anthrax toxin selectively targets blood vessels that feed tumors and support their growth and spread, researchers have found.
-
New on NCI's Websites for July 2016
An NCI Cancer Currents blog post that provides updates on new NCI websites and other online content of interest to the cancer community.
-
3-D View of Mutations May Identify Potential Targets for Cancer Drugs
A new 3-D modeling tool may help identify mutations in cancer cells that could be targeted with new or existing drugs, a new study suggests.
-
Study Forecasts ‘Silver Tsunami’ of Cancer Survivors
According to an NCI study, the number of older cancer survivors will grow substantially over the next quarter century, increasing the demand for cancer and survivorship care.
-
Mouse Study Illuminates the Spread of Breast Cancer to Bone
Researchers have identified proteins that may regulate the movement of breast cancer cells into and out of bone marrow.
-
Setting the Stage for the Next Decade of Tobacco Control Research
A new report from an NCI working group lays out recommended priorities to help shape the institute’s future tobacco control research portfolio.
-
The Cancer Moonshot Summit: Reaching New Heights
A recap of the Cancer Moonshot national summit hosted by Vice President Joe Biden in Washington, D.C., on June 29, 2016, including a summary of the NCI-related activities that have been stimulated by the Cancer Moonshot.